SARS-CoV-2 RBD/hACE2

Sara M Villada-Troncoso1, Jenny Andrea Arévalo-Romero1,2, Vanessa Hernández Rivera3

  • 1Institute for the Study in Inborn Errors of Metabolism-IEIM, Faculty of Science, Pontificia Universidad Javeriana, Bogotá 110231, Colombia.

PubMed
概括

研究人员通过实验验证了三种 (BP2,BP9,BP11) 阻止SARS-CoV-2尖端蛋白与人体细胞结合. 酸BP2表现出最强大的抗病毒活性,显示出新的COVID-19治疗方法的前景.